Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 9617539 Modulation of UBE3A-ATS expression
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
June 25, 2013
0
Date of Patent
April 11, 2017
0
Patent Application Number
14409348
0
Patent Citations Received
US Patent 11685920 Angelman syndrome antisense treatment
0
US Patent 12129466 Compounds and methods for modulating UBE3A-ATS
0
Patent Inventor Names
Arthur L. Beaudet
0
Linyan Meng
0
Amanda Ward
0
Frank Rigo
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
9617539
0
Patent Primary Examiner
Dana Shin
0
Find more entities like US Patent 9617539 Modulation of UBE3A-ATS expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE